During the past decade, Park-Klinik Weißensee conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Park-Klinik Weißensee" #1 collaborator was "B. Braun Medical France" with 1 trials as a collaborator, "Center for Clinical Trials Philipps University Marburg" with 1 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator and "Raylytic GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Park-Klinik Weißensee" are "Arthritis, Rheumatoid" (1 trials), "Estrogen Receptor Positive Tumor" (1 trials), "Genu Valgum or Varum" (1 trials), "Human Epidermal Growth Factor Receptor 2 Negative Tumor" (1 trials) and "Intra-Articular Fractures" (1 trials). Many other conditions were trialed in "Park-Klinik Weißensee" in a lesser frequency.

Most popular intervention types in "Park-Klinik Weißensee" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "Observation" (1 trials), "Panitumumab" (1 trials) and "UHMWPE with Vitamin E" (1 trials). Other intervention names were less common.

The vast majority of trials in "Park-Klinik Weißensee" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Park-Klinik Weißensee". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Park-Klinik Weißensee, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Park-Klinik Weißensee, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".